| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |